Copyright
©The Author(s) 2017.
World J Gastrointest Oncol. May 15, 2017; 9(5): 228-234
Published online May 15, 2017. doi: 10.4251/wjgo.v9.i5.228
Published online May 15, 2017. doi: 10.4251/wjgo.v9.i5.228
Table 1 Costs of disposable instruments for laparoscopic surgery and open surgery
| Item | Price |
| Laparoscopic surgery | |
| Ligasure Impact 5 mm, Medtronic, Ireland1 | € 448.22 |
| Ligasure Impact 10 mm, Medtronic, Ireland1 | € 376.00 |
| Autosuture endobag, endocatch, Medtronic, Ireland1 | € 63.56 |
| Autosuture EndoGIA 12 mm, Medtronic, Ireland1 | € 203.00 |
| Reload EndoGIA purple 45, Medtronic, Ireland1 | € 173.00 |
| Reload EndoGIA purple 60, Medtronic, Ireland1 | € 176.00 |
| Reload EndoGIA Gold 45, Medtronic, Ireland1 | € 181.00 |
| Endopaddle 12 mm, Medtronic, Ireland1 | € 81.84 |
| Alexis small/medium, applied medical | € 31.00 |
| Endoshear 5 mm, Medtronic, Ireland1 | € 73.50 |
| EEA XL, Covidien United States | € 439.62 |
| EEA Orvil, Covidien United States | € 94.20 |
| Bladeless trocar 5 mm, Medtronic, Ireland1 | € 48.88 |
| Bladeless trocar 5-12 mm, Medtronic, Ireland1 | € 48.88 |
| Blunt trocar 5-12 mm, Medtronic, Ireland1 | € 47.81 |
| Pyramidal bladed trocar 10-15 mm, Medtronic, Ireland1 | € 80.43 |
| Hem-o-lok L filling, Weck United States | € 23.00 |
| Hem-o-lok XL filling, Weck United States | € 23.00 |
| Open surgery | |
| Ligasure Impact, Medtronic, Ireland1 | € 343.80 |
| Purssting stapler, Medtronic, Ireland1 | € 57.34 |
| TA Green 30, Medtronic, Ireland1 | € 106.30 |
| Reload TA Green 30, Medtronic, Ireland1 | € 60.50 |
| TA Green 60, Medtronic, Ireland1 | € 110.09 |
| Reload TA Green 60, Medtronic, Ireland1 | € 65.00 |
| GIA Blue 60, Medtronic, Ireland1 | € 119.68 |
| Reload GIA Blue 60, Medtronic, Ireland1 | € 75.51 |
| GIA Blue 80, Medtronic, Ireland1 | € 147.48 |
| Reload GIA Blue 80, Medtronic, Ireland1 | € 81.74 |
| GIA Green 80, Medtronic, Ireland1 | € 148.96 |
| Reload GIA Green 80, Medtronic, Ireland1 | € 81.74 |
| CEEA 21, Medtronic, Ireland1 | € 408.97 |
| CEEA 25, Medtronic, Ireland1 | € 384.48 |
| CEEA 28, Medtronic, Ireland1 | € 388.33 |
| CEEA 25 XL, Medtronic, Ireland1 | € 439.62 |
Table 2 Baseline characteristics n (%)
| Open gastrectomy (n = 25, 32%) | Laparoscopic gastrectomy (n = 52, 68%) | P value | |
| Age | 70.0 (± 10, 46-85) | 68 ± 9, 50-87) | 0.470 |
| Sex (male/female) | 17/8 | 32/20 | 0.623 |
| BMI1 | 25 ± 4, 18-36 | 25 ± 5, 15-38 | 0.824 |
| CCI2 | 0.158 | ||
| 0-2 | 16 (64) | 27 (52) | |
| 3-4 | 7(28) | 11 (21) | |
| > 4 | 2 (8) | 14 (27) | |
| Tumour stage3 | 0.681 | ||
| 0 | 0 (0.0) | 2 (4) | |
| 11 | 4 (16) | 11 (21) | |
| 12 | 6 (24) | 15 (29) | |
| 2 | 5 (20) | 4 (8) | |
| 31 | 4 (16) | 10 (19) | |
| 32 | 3 (12) | 4 (8) | |
| 4 | 3 (12) | 6 (11) | |
| Subtotal gastrectomy | 16 (64) | 38 (73) | 0.436 |
| Total gastrectomy | 9 (36) | 14 (27) | |
| Neoadjuvant chemotherapy | 11 (44) | 36 (69) | 0.046 |
Table 3 Primary outcome, costs of surgery, hospital admission and intensive care unit stay
| Costs (in euro's) | Open gastrectomy (n = 25, 32.5%) | Laparoscopic gastrectomy (n = 52, 67.5%) | P value |
| Surgical instrumentation | 1181 ± 680 | 2270 ± 670 | < 0.001 |
| Operating theatre use | 2545 ± 1268 | 3819 ± 865 | < 0.001 |
| Ward stay | 2218 ± 1810 | 1381 ± 1298 | 0.023 |
| ICU stay | 1729 ± 6499 | 716 ± 3299 | 0.366 |
| Admission | 3947 ± 6719 | 2097 ± 4419 | 0.153 |
| Total costs | 7673 ± 8064 | 8187 ± 4864 | 0.729 |
Table 4 Secondary outcome parameters
| Open gastrectomy (n = 25, 32.5%) | Laparoscopic gastrectomy (n = 52, 67.5%) | P value | |
| Intraoperative blood loss (mL) | 592 (± 529, 100-2500) | 267 (± 316, 20-2000)1 | 0.002 |
| OR time (min) | 191 (± 95, range 95-554) | 286 (± 65, range 207-597) | < 0.001 |
| Lymph node yield (n) | 25 (± 10, 751) | 26 (± 8, 10-47) | 0.651 |
| Any complication | 15 (60%) | 16 (31%) | 0.025 |
| Grade Clavien-Dindo ≥ 3a | 7 (28%) | 6 (12%) | 0.104 |
| Anastomotic leakage | 3 (12%) | 2 (4%) | 0.322 |
| Mean length of stay (d) | 15 (± 14, 5-59) | 9 (± 12, 2-84) | 0.044 |
| Mean ICU stay (d) | 3 (± 10, 0-49) | 1 (± 5, 0-35) | 0.366 |
| Readmission | 4 (16%) | 6 (12%) | 0.720 |
- Citation: Tegels JJ, Silvius CE, Spauwen FE, Hulsewé KW, Hoofwijk AG, Stoot JH. Introduction of laparoscopic gastrectomy for gastric cancer in a Western tertiary referral centre: A prospective cost analysis during the learning curve. World J Gastrointest Oncol 2017; 9(5): 228-234
- URL: https://www.wjgnet.com/1948-5204/full/v9/i5/228.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i5.228
